Request for Covid-19 Impact Assessment of this Report
The United States Human Thrombin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Thrombin market, reaching US$ million by the year 2028. As for the Europe Human Thrombin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Human Thrombin players cover Baxter, CSL, Grifols, and Octapharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Thrombin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
500IU
1000IU
2500IU
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Baxter
CSL
Grifols
Octapharma
Kedrion
RAAS
Hualan Bio
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Thrombin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Human Thrombin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Human Thrombin by Country/Region, 2017, 2022 & 2028
2.2 Human Thrombin Segment by Type
2.2.1 500IU
2.2.2 1000IU
2.2.3 2500IU
2.3 Human Thrombin Sales by Type
2.3.1 Global Human Thrombin Sales Market Share by Type (2017-2022)
2.3.2 Global Human Thrombin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Human Thrombin Sale Price by Type (2017-2022)
2.4 Human Thrombin Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Human Thrombin Sales by Application
2.5.1 Global Human Thrombin Sale Market Share by Application (2017-2022)
2.5.2 Global Human Thrombin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Human Thrombin Sale Price by Application (2017-2022)
3 Global Human Thrombin by Company
3.1 Global Human Thrombin Breakdown Data by Company
3.1.1 Global Human Thrombin Annual Sales by Company (2020-2022)
3.1.2 Global Human Thrombin Sales Market Share by Company (2020-2022)
3.2 Global Human Thrombin Annual Revenue by Company (2020-2022)
3.2.1 Global Human Thrombin Revenue by Company (2020-2022)
3.2.2 Global Human Thrombin Revenue Market Share by Company (2020-2022)
3.3 Global Human Thrombin Sale Price by Company
3.4 Key Manufacturers Human Thrombin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Thrombin Product Location Distribution
3.4.2 Players Human Thrombin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Thrombin by Geographic Region
4.1 World Historic Human Thrombin Market Size by Geographic Region (2017-2022)
4.1.1 Global Human Thrombin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Human Thrombin Annual Revenue by Geographic Region
4.2 World Historic Human Thrombin Market Size by Country/Region (2017-2022)
4.2.1 Global Human Thrombin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Human Thrombin Annual Revenue by Country/Region
4.3 Americas Human Thrombin Sales Growth
4.4 APAC Human Thrombin Sales Growth
4.5 Europe Human Thrombin Sales Growth
4.6 Middle East & Africa Human Thrombin Sales Growth
5 Americas
5.1 Americas Human Thrombin Sales by Country
5.1.1 Americas Human Thrombin Sales by Country (2017-2022)
5.1.2 Americas Human Thrombin Revenue by Country (2017-2022)
5.2 Americas Human Thrombin Sales by Type
5.3 Americas Human Thrombin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Thrombin Sales by Region
6.1.1 APAC Human Thrombin Sales by Region (2017-2022)
6.1.2 APAC Human Thrombin Revenue by Region (2017-2022)
6.2 APAC Human Thrombin Sales by Type
6.3 APAC Human Thrombin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Thrombin by Country
7.1.1 Europe Human Thrombin Sales by Country (2017-2022)
7.1.2 Europe Human Thrombin Revenue by Country (2017-2022)
7.2 Europe Human Thrombin Sales by Type
7.3 Europe Human Thrombin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Thrombin by Country
8.1.1 Middle East & Africa Human Thrombin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Human Thrombin Revenue by Country (2017-2022)
8.2 Middle East & Africa Human Thrombin Sales by Type
8.3 Middle East & Africa Human Thrombin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Thrombin
10.3 Manufacturing Process Analysis of Human Thrombin
10.4 Industry Chain Structure of Human Thrombin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Thrombin Distributors
11.3 Human Thrombin Customer
12 World Forecast Review for Human Thrombin by Geographic Region
12.1 Global Human Thrombin Market Size Forecast by Region
12.1.1 Global Human Thrombin Forecast by Region (2023-2028)
12.1.2 Global Human Thrombin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Thrombin Forecast by Type
12.7 Global Human Thrombin Forecast by Application
13 Key Players Analysis
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Human Thrombin Product Offered
13.1.3 Baxter Human Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Human Thrombin Product Offered
13.2.3 CSL Human Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Human Thrombin Product Offered
13.3.3 Grifols Human Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Human Thrombin Product Offered
13.4.3 Octapharma Human Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Kedrion
13.5.1 Kedrion Company Information
13.5.2 Kedrion Human Thrombin Product Offered
13.5.3 Kedrion Human Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Kedrion Main Business Overview
13.5.5 Kedrion Latest Developments
13.6 RAAS
13.6.1 RAAS Company Information
13.6.2 RAAS Human Thrombin Product Offered
13.6.3 RAAS Human Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 RAAS Main Business Overview
13.6.5 RAAS Latest Developments
13.7 Hualan Bio
13.7.1 Hualan Bio Company Information
13.7.2 Hualan Bio Human Thrombin Product Offered
13.7.3 Hualan Bio Human Thrombin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hualan Bio Main Business Overview
13.7.5 Hualan Bio Latest Developments
14 Research Findings and Conclusion
Table 1. Human Thrombin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Human Thrombin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 500IU
Table 4. Major Players of 1000IU
Table 5. Major Players of 2500IU
Table 6. Global Human Thrombin Sales by Type (2017-2022) & (K Units)
Table 7. Global Human Thrombin Sales Market Share by Type (2017-2022)
Table 8. Global Human Thrombin Revenue by Type (2017-2022) & ($ million)
Table 9. Global Human Thrombin Revenue Market Share by Type (2017-2022)
Table 10. Global Human Thrombin Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Human Thrombin Sales by Application (2017-2022) & (K Units)
Table 12. Global Human Thrombin Sales Market Share by Application (2017-2022)
Table 13. Global Human Thrombin Revenue by Application (2017-2022)
Table 14. Global Human Thrombin Revenue Market Share by Application (2017-2022)
Table 15. Global Human Thrombin Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Human Thrombin Sales by Company (2020-2022) & (K Units)
Table 17. Global Human Thrombin Sales Market Share by Company (2020-2022)
Table 18. Global Human Thrombin Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Human Thrombin Revenue Market Share by Company (2020-2022)
Table 20. Global Human Thrombin Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Human Thrombin Producing Area Distribution and Sales Area
Table 22. Players Human Thrombin Products Offered
Table 23. Human Thrombin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Human Thrombin Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Human Thrombin Sales Market Share Geographic Region (2017-2022)
Table 28. Global Human Thrombin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Human Thrombin Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Human Thrombin Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Human Thrombin Sales Market Share by Country/Region (2017-2022)
Table 32. Global Human Thrombin Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Human Thrombin Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Human Thrombin Sales by Country (2017-2022) & (K Units)
Table 35. Americas Human Thrombin Sales Market Share by Country (2017-2022)
Table 36. Americas Human Thrombin Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Human Thrombin Revenue Market Share by Country (2017-2022)
Table 38. Americas Human Thrombin Sales by Type (2017-2022) & (K Units)
Table 39. Americas Human Thrombin Sales Market Share by Type (2017-2022)
Table 40. Americas Human Thrombin Sales by Application (2017-2022) & (K Units)
Table 41. Americas Human Thrombin Sales Market Share by Application (2017-2022)
Table 42. APAC Human Thrombin Sales by Region (2017-2022) & (K Units)
Table 43. APAC Human Thrombin Sales Market Share by Region (2017-2022)
Table 44. APAC Human Thrombin Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Human Thrombin Revenue Market Share by Region (2017-2022)
Table 46. APAC Human Thrombin Sales by Type (2017-2022) & (K Units)
Table 47. APAC Human Thrombin Sales Market Share by Type (2017-2022)
Table 48. APAC Human Thrombin Sales by Application (2017-2022) & (K Units)
Table 49. APAC Human Thrombin Sales Market Share by Application (2017-2022)
Table 50. Europe Human Thrombin Sales by Country (2017-2022) & (K Units)
Table 51. Europe Human Thrombin Sales Market Share by Country (2017-2022)
Table 52. Europe Human Thrombin Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Human Thrombin Revenue Market Share by Country (2017-2022)
Table 54. Europe Human Thrombin Sales by Type (2017-2022) & (K Units)
Table 55. Europe Human Thrombin Sales Market Share by Type (2017-2022)
Table 56. Europe Human Thrombin Sales by Application (2017-2022) & (K Units)
Table 57. Europe Human Thrombin Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Human Thrombin Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Human Thrombin Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Human Thrombin Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Human Thrombin Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Human Thrombin Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Human Thrombin Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Human Thrombin Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Human Thrombin Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Human Thrombin
Table 67. Key Market Challenges & Risks of Human Thrombin
Table 68. Key Industry Trends of Human Thrombin
Table 69. Human Thrombin Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Human Thrombin Distributors List
Table 72. Human Thrombin Customer List
Table 73. Global Human Thrombin Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Human Thrombin Sales Market Forecast by Region
Table 75. Global Human Thrombin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Human Thrombin Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Human Thrombin Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Human Thrombin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Human Thrombin Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Human Thrombin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Human Thrombin Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Human Thrombin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Human Thrombin Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Human Thrombin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Human Thrombin Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Human Thrombin Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Human Thrombin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Human Thrombin Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Human Thrombin Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Human Thrombin Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Human Thrombin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Human Thrombin Revenue Market Share Forecast by Application (2023-2028)
Table 93. Baxter Basic Information, Human Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 94. Baxter Human Thrombin Product Offered
Table 95. Baxter Human Thrombin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Baxter Main Business
Table 97. Baxter Latest Developments
Table 98. CSL Basic Information, Human Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 99. CSL Human Thrombin Product Offered
Table 100. CSL Human Thrombin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. CSL Main Business
Table 102. CSL Latest Developments
Table 103. Grifols Basic Information, Human Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 104. Grifols Human Thrombin Product Offered
Table 105. Grifols Human Thrombin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Grifols Main Business
Table 107. Grifols Latest Developments
Table 108. Octapharma Basic Information, Human Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 109. Octapharma Human Thrombin Product Offered
Table 110. Octapharma Human Thrombin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Octapharma Main Business
Table 112. Octapharma Latest Developments
Table 113. Kedrion Basic Information, Human Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 114. Kedrion Human Thrombin Product Offered
Table 115. Kedrion Human Thrombin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Kedrion Main Business
Table 117. Kedrion Latest Developments
Table 118. RAAS Basic Information, Human Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 119. RAAS Human Thrombin Product Offered
Table 120. RAAS Human Thrombin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. RAAS Main Business
Table 122. RAAS Latest Developments
Table 123. Hualan Bio Basic Information, Human Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 124. Hualan Bio Human Thrombin Product Offered
Table 125. Hualan Bio Human Thrombin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Hualan Bio Main Business
Table 127. Hualan Bio Latest Developments
List of Figures
Figure 1. Picture of Human Thrombin
Figure 2. Human Thrombin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Thrombin Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Human Thrombin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Human Thrombin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 500IU
Figure 10. Product Picture of 1000IU
Figure 11. Product Picture of 2500IU
Figure 12. Global Human Thrombin Sales Market Share by Type in 2021
Figure 13. Global Human Thrombin Revenue Market Share by Type (2017-2022)
Figure 14. Human Thrombin Consumed in Hospital
Figure 15. Global Human Thrombin Market: Hospital (2017-2022) & (K Units)
Figure 16. Human Thrombin Consumed in Clinic
Figure 17. Global Human Thrombin Market: Clinic (2017-2022) & (K Units)
Figure 18. Human Thrombin Consumed in Other
Figure 19. Global Human Thrombin Market: Other (2017-2022) & (K Units)
Figure 20. Global Human Thrombin Sales Market Share by Application (2017-2022)
Figure 21. Global Human Thrombin Revenue Market Share by Application in 2021
Figure 22. Human Thrombin Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Human Thrombin Revenue Market Share by Company in 2021
Figure 24. Global Human Thrombin Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Human Thrombin Revenue Market Share by Geographic Region in 2021
Figure 26. Global Human Thrombin Sales Market Share by Region (2017-2022)
Figure 27. Global Human Thrombin Revenue Market Share by Country/Region in 2021
Figure 28. Americas Human Thrombin Sales 2017-2022 (K Units)
Figure 29. Americas Human Thrombin Revenue 2017-2022 ($ Millions)
Figure 30. APAC Human Thrombin Sales 2017-2022 (K Units)
Figure 31. APAC Human Thrombin Revenue 2017-2022 ($ Millions)
Figure 32. Europe Human Thrombin Sales 2017-2022 (K Units)
Figure 33. Europe Human Thrombin Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Human Thrombin Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Human Thrombin Revenue 2017-2022 ($ Millions)
Figure 36. Americas Human Thrombin Sales Market Share by Country in 2021
Figure 37. Americas Human Thrombin Revenue Market Share by Country in 2021
Figure 38. United States Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Human Thrombin Sales Market Share by Region in 2021
Figure 43. APAC Human Thrombin Revenue Market Share by Regions in 2021
Figure 44. China Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Human Thrombin Sales Market Share by Country in 2021
Figure 51. Europe Human Thrombin Revenue Market Share by Country in 2021
Figure 52. Germany Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Human Thrombin Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Human Thrombin Revenue Market Share by Country in 2021
Figure 59. Egypt Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Human Thrombin Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Human Thrombin in 2021
Figure 65. Manufacturing Process Analysis of Human Thrombin
Figure 66. Industry Chain Structure of Human Thrombin
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...